Aveo Pharmaceuticals, Inc.
Clinical trials sponsored by Aveo Pharmaceuticals, Inc., explained in plain language.
Biopharmaceutical company focused on oncology therapies.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
-
New drug cocktail aims to extend life in Tough-to-Treat head and neck cancer
Disease control Recruiting nowThis Phase 3 trial is testing whether adding ficlatuzumab to the standard drug cetuximab helps people with recurrent or metastatic HPV-negative head and neck cancer live longer. About 410 adults will be randomly assigned to receive either the combination or a placebo plus cetuxim…
Phase: PHASE3 • Sponsor: AVEO Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
New drug aims to reverse wasting in cancer patients
Symptom relief Recruiting nowThis early-stage trial tests AV-380, an antibody that blocks a protein linked to cancer-related weight loss (cachexia). About 30 adults with advanced solid tumors and high GDF-15 levels will receive AV-380 alongside their standard chemotherapy. The main goal is to check safety an…
Phase: PHASE1 • Sponsor: AVEO Pharmaceuticals, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 08:09 UTC